Cargando…
Critical-illness-Myopathie und -Polyneuropathie
An average of 50–80% of patients treated in the intensive care unit is affected by disturbances of neuromuscular functions due to damage to the nerves and muscles, which has led to the terms critical illness polyneuropathy and myopathy. Both components occur in 30–50% of patients, while the others p...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Medizin
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095927/ https://www.ncbi.nlm.nih.gov/pubmed/28875277 http://dx.doi.org/10.1007/s00063-017-0339-0 |
_version_ | 1783510714146619392 |
---|---|
author | Senger, D. Erbguth, F. |
author_facet | Senger, D. Erbguth, F. |
author_sort | Senger, D. |
collection | PubMed |
description | An average of 50–80% of patients treated in the intensive care unit is affected by disturbances of neuromuscular functions due to damage to the nerves and muscles, which has led to the terms critical illness polyneuropathy and myopathy. Both components occur in 30–50% of patients, while the others predominantly show a pure myopathy, while pure neuropathy is rare. Meanwhile, the descriptive term of the concept as intensive care unit-acquired weakness (ICUAW) is preferred. The most significant risk factors for the development of ICUAW are sepsis, multiorgan dysfunction and acute respiratory distress syndrome (ARDS). In at least one third of patients, persistent impairment by paralysis, sensory disturbances and balance problems persist when they leave the ICU. At approximately 10%, these leg-accentuated and highly everyday relevant disorders persist over the first year after ICU therapy. Pure myopathy rarely leads to residual disturbances, while the neuropathic component is responsible for long-term impairments. |
format | Online Article Text |
id | pubmed-7095927 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Springer Medizin |
record_format | MEDLINE/PubMed |
spelling | pubmed-70959272020-03-26 Critical-illness-Myopathie und -Polyneuropathie Senger, D. Erbguth, F. Med Klin Intensivmed Notfmed Leitthema An average of 50–80% of patients treated in the intensive care unit is affected by disturbances of neuromuscular functions due to damage to the nerves and muscles, which has led to the terms critical illness polyneuropathy and myopathy. Both components occur in 30–50% of patients, while the others predominantly show a pure myopathy, while pure neuropathy is rare. Meanwhile, the descriptive term of the concept as intensive care unit-acquired weakness (ICUAW) is preferred. The most significant risk factors for the development of ICUAW are sepsis, multiorgan dysfunction and acute respiratory distress syndrome (ARDS). In at least one third of patients, persistent impairment by paralysis, sensory disturbances and balance problems persist when they leave the ICU. At approximately 10%, these leg-accentuated and highly everyday relevant disorders persist over the first year after ICU therapy. Pure myopathy rarely leads to residual disturbances, while the neuropathic component is responsible for long-term impairments. Springer Medizin 2017-09-05 2017 /pmc/articles/PMC7095927/ /pubmed/28875277 http://dx.doi.org/10.1007/s00063-017-0339-0 Text en © Springer Medizin Verlag GmbH 2017 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Leitthema Senger, D. Erbguth, F. Critical-illness-Myopathie und -Polyneuropathie |
title | Critical-illness-Myopathie und -Polyneuropathie |
title_full | Critical-illness-Myopathie und -Polyneuropathie |
title_fullStr | Critical-illness-Myopathie und -Polyneuropathie |
title_full_unstemmed | Critical-illness-Myopathie und -Polyneuropathie |
title_short | Critical-illness-Myopathie und -Polyneuropathie |
title_sort | critical-illness-myopathie und -polyneuropathie |
topic | Leitthema |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095927/ https://www.ncbi.nlm.nih.gov/pubmed/28875277 http://dx.doi.org/10.1007/s00063-017-0339-0 |
work_keys_str_mv | AT sengerd criticalillnessmyopathieundpolyneuropathie AT erbguthf criticalillnessmyopathieundpolyneuropathie |